By Katharine Gammon Today more than 55 million people around the world have Alzheimer’s disease and other dementias, which ravage the minds of those who suffer from them and have devastating impacts on their family members. In spite of decades of research, the precise origins of these diseases continue to elude scientists, though numerous factors have been found to be associated with higher risk, including genetics and various lifestyle and environmental factors. Nautilus Members enjoy an ad-free experience. Log in or Join now . The quest has recently taken a turn to a newer model for studying the brain: brain organoids. These three-dimensional clumps of neuronal tissue derived from human stem cells have been used to study everything from epilepsy to the origins of consciousness. And now, researchers in Massachusetts are slamming them with miniature metal pistons to test out whether they can lend credence to a controversial hypothesis: that concussions might reactivate a common virus in the brain, increasing dementia risk. A decade of research suggests traumatic brain injury, whether from accidents or high-contact sports, is a standout risk factor for Alzheimer’s and other forms of neurodegenerative decline. Some estimates suggest that up to 10 percent of cases could be attributed to at least one prior head injury, but why is not fully understood. Separately, a growing body of research proposes that viral infection, including a common virus known as herpes simplex one, can also increase susceptibility to these diseases. But all three things—head trauma, viral infection, and dementia—have not been directly connected in experimental research, until now. One of the challenges in getting to the roots of dementia is that humans lead complex, messy lives. In the soup of risk factors—from high blood pressure to loneliness to genetic inheritance—it can be hard to filter out the most impactful forces that have contributed to the onset of any one dementia case. There are no ethical ways to test these questions on humans, of course, while using lab animals presents its own ethical and cost challenges. Animals are never a perfect match for humans anyway, and dementia-related findings in animals have so far not translated well to human patients. © 2025 NautilusNext Inc.,

Keyword: Alzheimers; Brain Injury/Concussion
Link ID: 29646 - Posted: 01.29.2025

By Katherine Ellison “American Ninja Warrior” contestant Jimmy Choi was 27 when he was diagnosed with young-onset Parkinson’s disease after a routine medical exam. Today, Choi, 50, is an adviser to the Michael J. Fox Foundation for Parkinson’s Research who champions physical fitness and works to inspire others via public speaking and social media posts. More than 1 million Americans have Parkinson’s disease, a neurological illness that can cause tremors, loss of balance, confusion and depression. Choi spent the eight years after his diagnosis in denial as his symptoms grew worse. After a mortifying fall, however, his perspective changed, and he embraced exercise — in a big way. Since 2011, the Chicago-based former tech executive (he retired from full-time work in 2018, though he still works as a consultant) has run 16 marathons and earned three Guinness World records, the most recent in 2023 for consecutive double high five push-ups. He has also competed seven times on “American Ninja Warrior,” the reality-TV show in which contestants make their way past daunting obstacles, crossing unstable bridges, running up walls and leaping through the air, all while trying to avoid falling into a large pool of water. Last year Choi finished his seventh, and, he insists, last “Ninja” appearance. It’s set to air this spring. Q: What led to your diagnosis? A: It was a routine exam for health insurance, in 2003. A nurse noticed the way I was walking and said I should talk to my doctor. I had to see four neurologists before I got diagnosed, and for several years afterward, I lost my motivation. I started isolating from friends, gained a lot of weight and couldn’t walk without a cane.

Keyword: Parkinsons
Link ID: 29645 - Posted: 01.29.2025

By Tina Hesman Saey After nearly 350 years, a depiction of a bee’s brain is getting some buzz. A manuscript created in the mid-1670s contains the oldest known depiction of an insect’s brain, historian of science Andrea Strazzoni of the University of Turin in Italy reports January 29 in Royal Society Notes and Records. Handwritten by Dutch biologist and microscopist Johannes Swammerdam, the manuscript contains a detailed description and drawing of a honeybee drone’s brain. The illustration, based on his own dissections, was just one of Swammerdam’s firsts. In 1658, he was also the first to see and describe red blood cells. Since no one had previously reported dissecting a bee brain, Swammerdam based his descriptions on what was known about the brain anatomy of humans and other mammals. “He knew what to expect from or to imagine in his observations: in particular, the pineal gland and the cerebellum,” Strazzoni writes. Bees have neither of those parts but have brain structures that the 17th century scientist mistook for them. But Swammerdam deserves some slack, Strazzoni suggests. He was working with single-lens microscopes and developing new techniques for dissecting and observing insects’ internal organs. Even with those crude instruments, he was able to identify some nerves and describe how parts of the brain connected. © Society for Science & the Public 2000–2025.

Keyword: Brain imaging; Evolution
Link ID: 29644 - Posted: 01.29.2025

By Ellen Barry A study of more than 30,000 British adults diagnosed with attention deficit hyperactivity disorder, or A.D.H.D., found that, on average, they were dying earlier than their counterparts in the general population — around seven years earlier for men, and around nine for women. The study, which was published Thursday in The British Journal of Psychiatry, is believed to be the first to use all-cause mortality data to estimate life expectancy in people with A.D.H.D. Previous studies have pointed to an array of risks associated with the condition, among them poverty, mental health disorders, smoking and substance abuse. The authors cautioned that A.D.H.D. is substantially underdiagnosed and that the people in their study — most of them diagnosed as young adults — might be among the more severely affected. Still, they described their findings as “extremely concerning,” highlighting unmet needs that “require urgent attention.” “It’s a big number, and it is worrying,” said Joshua Stott, a professor of aging and clinical psychology at University College London and an author of the study. “I see it as likely to be more about health inequality than anything else. But it’s quite a big health inequality.” The study did not identify causes of early death among people with A.D.H.D. but found that they were twice as likely as the general population to smoke or abuse alcohol and that they had far higher rates of autism, self-harming behaviors and personality disorders than the general population. In adulthood, Dr. Stott said, “they find it harder to manage impulses, and have more risky behaviors.” He said health care systems might need to adjust in order to better serve people with A.D.H.D., who may have sensory sensitivity or difficulty managing time or communicating with clinicians during brief appointments. He said he hoped treatments for substance abuse or depression could be adapted for patients with A.D.H.D. © 2025 The New York Times Company

Keyword: ADHD; Drug Abuse
Link ID: 29643 - Posted: 01.25.2025

By Shaena Montanari For evolutionary neuroanatomists who compare diverse animal brains, access to a gold mine of 500,000 histological sections and whole mounts is now only a mouse-click away. The R. Glenn Northcutt Collection of Comparative Vertebrate Neuroanatomy and Embryology at Harvard University—which comprises 33,000 slides of tissue samples from more than 240 vertebrate genera—is one of the world’s largest and most diverse collections of its kind. Northcutt, a prolific comparative vertebrate neuroanatomist and emeritus professor of neurosciences at the University of California, San Diego, amassed the collection over the course of five decades. Since 2021, James Hanken, research professor of biology at Harvard University and curator at the Museum of Comparative Zoology, has led an effort to digitize it. The scanning process is still ongoing and may take another two years to complete, Hanken says, but more than 8,000 slides are already publicly available in two online data repositories: MCZBase and MorphoSource. A comprehensive inventory of the entire collection appears in a paper Hanken and his colleagues published last week in the Bulletin of the Museum of Comparative Zoology. It provides researchers with an in-depth guide for using the collection, Hanken says. Few other resources of this type are available online to researchers interested in evolutionary biology and brain anatomy, says Andrew Iwaniuk, professor of neuroscience at the University of Lethbridge. For example, neither the Welker Comparative Anatomy Collection nor the Starr Collection, both housed at the U.S. National Museum of Health and Medicine in Silver Spring, Maryland, are available online. To access slide collections such as these, scientists have had to travel to see them in person, which can be difficult for those outside the United States, Iwaniuk adds. © 2025 Simons Foundation

Keyword: Brain imaging; Evolution
Link ID: 29642 - Posted: 01.25.2025

By Smriti Mallapaty For the first time, scientists have tracked microplastics moving through the bodies of mice in real time1. The tiny plastic particles are gobbled up by immune cells, travel through the bloodstream and eventually become lodged in blood vessels in the brain. It’s not clear whether such obstructions occur in people, say researchers, but they did seem to affect the mice’s movement. Microplastics are specks of plastic, less than 5 millimetres long, that can be found everywhere, from the deep ocean to Antarctic ice. They are in the air we breathe, the water we drink and the food we eat. They can even enter our bloodstreams directly through plastic medical devices. Studies show that microplastics, and smaller nanoplastics, have made their way into humans’ brains, livers and kidneys, but researchers are just beginning to understand what happens to these plastic intruders and their effect on human health. One study last year, for example, found that people with micro- and nano-plastics in fatty deposits in their main artery were more likely to experience a heart attack, stroke or death2. In the latest study, published in Science Advances today, Haipeng Huang, a biomedical researcher at Peking University in Beijing, and his colleagues wanted to better understand how microplastics affect the brain. They used a fluorescence imaging technique called miniature two-photon microscopy to observe what was happening in mouse brains through a transparent window surgically implanted into the animal’s skull. The imaging technique can trace microplastics as they move through the bloodstream, says Eliane El Hayek, an environmental-health researcher at University of New Mexico in Albuquerque. “It’s very interesting, and very helpful.” © 2025 Springer Nature Limited

Keyword: Neurotoxins; Stroke
Link ID: 29641 - Posted: 01.25.2025

By Meredith Wadman, Jocelyn Kaiser President Donald Trump’s return to the White House is already having a big impact at the $47.4 billion U.S. National Institutes of Health (NIH), with the new administration imposing a wide range of restrictions, including the abrupt cancellation of meetings such as grant review panels. Officials have also ordered a communications pause, a freeze on hiring, and an indefinite ban on travel. The moves have generated extensive confusion and uncertainty at the nation’s largest research agency, which has become a target for Trump’s political allies. “The impact of the collective executive orders and directives appears devastating,” one senior NIH employee says. Today, for example, officials halted midstream a training workshop for junior scientists, called off a workshop on adolescent learning minutes before it was to begin, and canceled meetings of two advisory councils. Panels that were scheduled to review grant proposals also received eleventh-hour word that they wouldn’t be meeting. “This kind of disruption could have long ripple effects,” says Jane Liebschutz, an opioid addiction researcher at the University of Pittsburgh who posted on Bluesky about the canceled study sections. “Even short delays will put the United States behind in research.” She and colleagues are feeling “a lot of uncertainty, fear, and panic,” Liebschutz says. The hiring freeze is governmentwide, whereas a pause on communications and travel appears to be limited to the Department of Health and Human Services (HHS), NIH’s parent agency. Such pauses are not unprecedented when a new administration comes in. But some NIH staff suggested these measures, which include pulling job ads and rescinding offers, are more extreme than any previously. Researchers who planned to present their work at meetings must cancel their trips, as must NIH officials promoting agency programs off site or visiting distant branches of the agency. “Future travel requests for any reason are not authorized and should not be approved,” the memo said.

Keyword: Miscellaneous
Link ID: 29640 - Posted: 01.25.2025

By Yasemin Saplakoglu Imagine you’re on a first date, sipping a martini at a bar. You eat an olive and patiently listen to your date tell you about his job at a bank. Your brain is processing this scene, in part, by breaking it down into concepts. Bar. Date. Martini. Olive. Bank. Deep in your brain, neurons known as concept cells are firing. You might have concept cells that fire for martinis but not for olives. Or ones that fire for bars — perhaps even that specific bar, if you’ve been there before. The idea of a “bank” also has its own set of concept cells, maybe millions of them. And there, in that dimly lit bar, you’re starting to form concept cells for your date, whether you like him or not. Those cells will fire when something reminds you of him. Concept neurons fire for their concept no matter how it is presented: in real life or a photo, in text or speech, on television or in a podcast. “It’s more abstract, really different from what you’re seeing,” said Elizabeth Buffalo (opens a new tab), a neuroscientist at the University of Washington. For decades, neuroscientists mocked the idea that the brain could have such intense selectivity, down to the level of an individual neuron: How could there be one or more neurons for each of the seemingly countless concepts we engage with over a lifetime? “It’s inefficient. It’s not economic,” people broadly agreed, according to the neurobiologist Florian Mormann (opens a new tab) at the University of Bonn. But when researchers identified concept cells in the early 2000s, the laughter started to fade. Over the past 20 years, they have established that concept cells not only exist but are critical to the way the brain abstracts and stores information. New studies, including one recently published in Nature Communications, have suggested that they may be central to how we form and retrieve memory. © 2025 Simons Foundation

Keyword: Learning & Memory; Attention
Link ID: 29639 - Posted: 01.22.2025

By Holly Barker Previously unrecognized genetic changes on the X chromosome of autistic people could explain the higher prevalence of the condition among men and boys than among women and girls, according to two new studies. About 60 variants are more common in people with autism than in those without the condition, an analysis of roughly 15,000 X chromosomes revealed. Several of the variants are in Xp22.11, a region of the X chromosome linked to autism in boys and men. In the second study, the team pinpointed 27 autism-linked variants in DDX53, one of the genes in the vulnerable region that had not been tied to the condition in past research. Those findings could help explain why autism is diagnosed three to four times more often in boys than girls, according to the study investigators, led by Stephen Scherer, chief of research at SickKids Research Institute. Although that disparity is likely influenced by social factors—male-only studies could lead to autism being less recognizable in women and girls, and girls may be conditioned to mask their autism traits—there is also a clear biological component. The X chromosome plays an outsized role in brain development, and many genes on the chromosome are strongly linked to autism, previous studies have found. Still, the sex chromosomes have been mostly ignored in genetic searches of autism variants, says Aaron Besterman, associate clinical professor of psychiatry at the University of California, San Diego, who was not involved in the work. “It’s been a dirty little secret that for a long time the X chromosome has not been well interrogated from a genetics perspective,” he says. Sex chromosomes are often sidelined because of difficulties interpreting data, given that men possess half the number of X-linked genes as women. What’s more, random inactivation of X chromosomes makes it hard to tell how a single variant is expressed in female tissues. And the existence of pseudoautosomal regions—stretches of DNA that behave like regular chromosomes and escape inactivation—complicates matters further. © 2025 Simons Foundation

Keyword: Autism; Sexual Behavior
Link ID: 29638 - Posted: 01.22.2025

Hannah Devlin Science correspondent A groundbreaking NHS trial will attempt to boost patients’ mood using a brain-computer-interface that directly alters brain activity using ultrasound. The device, which is designed to be implanted beneath the skull but outside the brain, maps activity and delivers targeted pulses of ultrasound to “switch on” clusters of neurons. Its safety and tolerability will be tested on about 30 patient in the £6.5m trial, funded by the UK’s Advanced Research and Invention Agency (Aria). In future, doctors hope the technology could revolutionise the treatment of conditions such as depression, addiction, OCD and epilepsy by rebalancing disrupted patterns of brain activity. Jacques Carolan, Aria’s programme director, said: “Neurotechnologies can help a much broader range of people than we thought. Helping with treatment resistant depression, epilepsy, addiction, eating disorders, that is the huge opportunity here. We are at a turning point in both the conditions we hope we can treat and the new types of technologies emerging to do that.” The trial follows rapid advances in brain-computer-interface (BCI) technology, with Elon Musk’s company Neuralink launching a clinical trial in paralysis patients last year and another study restoring communication to stroke patients by translating their thoughts directly into speech. However, the technologies raise significant ethical issues around the ownership and privacy of data, the possibility of enhancement and the risk of neuro-discrimination, whereby brain data might be used to judge a person’s suitability for employment or medical insurance. © 2025 Guardian News & Media Limited

Keyword: Depression; Brain imaging
Link ID: 29637 - Posted: 01.22.2025

By Angie Voyles Askham More than 150 years after the first known description of Huntington’s disease and 32 years after the causative gene, HTT, was identified, new evidence has emerged to explain how variants linked to the disease devastate the brain: The toxicity comes not from the initial variant itself but rather from its dynamic expansion past a set threshold in specific cells, according to a study published today in Cell. The results help explain why most people with Huntington’s disease don’t start to show symptoms—including muscle rigidity, irregular movements and severe psychological issues—until age 30 to 50, with the gradual loss of striatal projection neurons, also called medium spiny neurons, says co-lead researcher Steven McCarroll, professor of biomedical science and genetics at Harvard Medical School. “We hadn’t been thinking about mutations as dynamic things” that become toxic only later in life, he says. The HTT variants associated with Huntington’s disease all have extra repeats of the DNA triplet CAG. Typical people carry about 15 to 30 of these repeats, and those with the disease tend to have 40 or more. The disease-linked expansions, which are known to grow even larger over time, result in a gangly version of the Huntington’s protein that is thought to cause neurons to malfunction and degenerate. But the expansion does not appear to affect a cell’s biology until it exceeds 150 CAG copies, according to the new study. And the repeats accumulate quietly over the course of years, and at different rates for different cells. Striatal projection neurons with more than 150 repeats have severely dysregulated transcriptomes, McCarroll and his colleagues found by analyzing gene expression in postmortem tissue from people with Huntington’s disease. But other cell types in the striatum, including oligodendrocytes and interneurons, do not end up with as many repeats, nor do they undergo similar transcriptomic changes, the work shows. © 2025 Simons Foundation

Keyword: Huntingtons; Genes & Behavior
Link ID: 29636 - Posted: 01.22.2025

Rachael Elward Lauren Ford Severance, which imagines a world where a person’s work and personal lives are surgically separated, will soon return to Apple TV+ for a second season. While the concept of this gripping piece of science fiction is far-fetched, it touches on some interesting neuroscience. Can a person’s mind really be surgically split in two? Remarkably, “split-brain” patients have existed since the 1940s. To control epilepsy symptoms, these patients underwent a surgery to separate the left and right hemispheres. Similar surgeries still happen today. Later research on this type of surgery showed that the separated hemispheres of split-brain patients could process information independently. This raises the uncomfortable possibility that the procedure creates two separate minds living in one brain. In season one of Severance, Helly R (Britt Lower) experienced a conflict between her “innie” (the side of her mind that remembered her work life) and her “outie” (the side outside of work). Similarly, there is evidence of a conflict between the two hemispheres of real split-brain patients. When speaking with split-brain patients, you are usually communicating with the left hemisphere of the brain, which controls speech. However, some patients can communicate from their right hemisphere by writing, for example, or arranging Scrabble letters. A young patient was asked what job he would like in the future. His left hemisphere chose an office job making technical drawings. His right hemisphere, however, arranged letters to spell “automobile racer”. Split brain patients have also reported “alien hand syndrome”, where one of their hands is perceived to be moving of its own volition. These observations suggest that two separate conscious “people” may coexist in one brain and may have conflicting goals. In Severance, however, both the innie and the outie have access to speech. This is one indicator that the fictional “severance procedure” must involve a more complex separation of the brain’s networks. © 2010–2025, The Conversation US, Inc.

Keyword: Learning & Memory; Consciousness
Link ID: 29635 - Posted: 01.18.2025

By Phie Jacobs For more than 30 years, scientists have known the genetic culprit behind Huntington disease, a devastating neurodegenerative disorder that causes cells deep in the brain to sicken and die. But they couldn’t account for why people who inherit the faulty gene variant take so long to develop symptoms, or why disease progression varies so widely from person to person. A study published today in Cell helps explain: In the brain cells that die off in Huntington, a repetitive stretch of a gene’s DNA gets longer and longer over a person’s life, and this accelerating expansion turns deadly to the cell—and ultimately to the person. The findings represent “a really remarkable insight,” says Leslie Thompson, a neuroscientist at the University of California, Irvine who wasn’t involved in the new research. “This study and some others are changing the way that we’re thinking about the disease.” People who develop Huntington inherit a flawed version of the HTT gene, which produces a protein called huntingtin. This gene contains an unusual stretch of DNA, where a sequence of three of its nucleotide bases—cytosine, adenine, and guanine, or CAG in genetic parlance—are repeated multiple times in a row. And although most people inherit versions of HTT with about 15 to 30 consecutive CAG repeats and never develop Huntington, those with 40 or more in the gene almost always have symptoms later in life, including psychological and cognitive problems and uncontrolled, jerking movements known as chorea. The genetic stutter produces an abnormally large, unstable version of the huntingtin protein, which forms clumps inside brain cells. The condition usually leads to early death, often from issues related to difficulty swallowing, injuries from falls, or suicide. The longer a person’s stretch of repeats, the earlier the disorder rears its head. Scientists originally thought the number of CAG repeats only increased as the HTT gene was passed down through generations; a child of a parent with Huntington might themselves develop the condition at an earlier age. But it turns out the length of this genetic “stutter” can change over a person’s life in at least some of their cells. A 2003 study analyzed brain samples donated by people who had died of Huntington and found shockingly large CAG expansions in a part of the brain known as the striatum.

Keyword: Huntingtons; Genes & Behavior
Link ID: 29634 - Posted: 01.18.2025

By Anna Victoria Molofsky Twenty years ago, a remarkable discovery upended our understanding of the range of elements that can shape neuronal function: A team in Europe demonstrated that enzymatic digestion of the extracellular matrix (ECM)—a latticework of proteins that surrounds all brain cells—could restore plasticity to the visual cortex even after the region’s “critical period” had ended. Other studies followed, showing that ECM digestion could also alter learning in the hippocampus and other brain circuits. These observations established that proteins outside neurons can control synaptic plasticity. We now know that up to 20 percent of the brain is extracellular space, filled with hundreds of ECM proteins—a “matrisome” that plays multiple roles, including modulating synaptic function and myelin formation. ECM genes in the human brain are different than those in other species, suggesting that the proteins they encode could be part of what makes our brains unique and keeps them healthy. In a large population study, posted as a preprint on bioRxiv last year, that examined blood protein biomarkers of organ aging, for example, the presence of ECM proteins was most highly correlated with a youthful brain. Matrisome proteins are also dysregulated in astrocytes from people at high risk for Alzheimer’s disease, another study showed. Despite the influence of these proteins and the ongoing work of a few dedicated researchers, however, the ECM field has not caught on. I would challenge a room full of neuroscientists to name one protein in the extracellular matrix. To this day, the only ECM components most neuroscientists have heard of are “perineuronal nets”—structures that play an important role in stabilizing synapses but make up just a tiny fraction of the matrisome. A respectable scientific journal, covering its own paper that identified a critical impact of ECM, called it “brain goop.” © 2025 Simons Foundation

Keyword: Learning & Memory; Glia
Link ID: 29633 - Posted: 01.18.2025

By Aimee Cunningham If cigarettes contained very little of the chemical that keeps people smoking, it could help smokers move away from these deadly products. That’s the rationale behind a new rule proposed on January 15 by the U.S. Food and Drug Administration, which seeks to limit the amount of the addictive chemical nicotine in cigarettes. The reduced-nicotine cigarettes would have less than 5 percent of the amount of nicotine that’s generally found in regular cigarettes. The rule would also cap the nicotine in certain other products in which the tobacco leaves are burned. The FDA rule is just one step toward reduced-nicotine cigarettes and other combusted tobacco products becoming the standard. This process would probably take many years, depending on the priorities of future administrations and whether the tobacco industry challenges the rule in court, as it has the FDA’s rule placing graphic warning labels on their products. The 2009 Family Smoking Prevention and Tobacco Control gave the FDA the authority to require graphic warning labels and to reduce nicotine in tobacco products. The idea for a nicotine limit has been around for decades. And the evidence supporting drastically lowering the amount of nicotine in combusted tobacco products has grown during that time. Randomized controlled trials of reduced-nicotine cigarettes report that people using them end up smoking fewer cigarettes per day. That’s also the case for studies that focused on groups at higher risk for smoking, including people who are socioeconomically disadvantaged and people with mental health conditions. © Society for Science & the Public 2000–2025.

Keyword: Drug Abuse
Link ID: 29632 - Posted: 01.18.2025

Hannah Devlin Science correspondent A powerful psychedelic that is used in healing ceremonies by Indigenous groups in the Amazon is being trialled as a pioneering approach to reduce problematic alcohol consumption. Dimethyltryptamine (DMT) is the active ingredient in ayahuasca, a hallucinogenic brew that has been used for thousands of years by shamans in South America. Scientists based at University College London are testing whether a one-off dose of the drug could help hazardous drinkers who want to reduce their alcohol intake. Alcohol addiction is notoriously difficult to overcome and there are few effective therapies available. “The current treatments really don’t work for a large proportion of people. For alcohol addiction, 50% of people relapse within three months and around 60-70% within three years,” said Prof Ravi Das, who is co-leading the trial at University College London with Prof Jeremy Skipper. “Treatment itself hasn’t changed fundamentally in 70 years, so there’s a desperate need for new drugs and treatment approaches. To the extent that DMT might provide a more effective treatment approach, it is worth exploring.” In its pure form, DMT is one of the most powerful psychoactive substances found in nature. “The dose we chose reliably produces strong effects,” said Dr Greg Cooper, a research fellow at UCL, adding that this included total out-of-body experiences, fully immersive hallucinations and entering colourful geometric landscapes. © 2025 Guardian News & Media Limited

Keyword: Drug Abuse
Link ID: 29631 - Posted: 01.18.2025

By Shaena Montanari Just as romantic partners exhibit more similar brain waves than do strangers when, say, drawing on an Etch A Sketch toy together, animal pairs also show neural synchrony during social interactions and cooperation tasks. “Neural synchrony is something that happens in these minute-to-minute engagements that you have with another individual,” says Zoe Donaldson, associate professor of behavioral neuroscience at the University of Colorado Boulder. But over time, too, pairs in a relationship learn to infer what their partner is going to do, she adds. In prairie voles, at least, that learning process may unfold at the molecular level in the form of “transcriptional synchrony,” according to a preprint Donaldson and her colleagues posted on bioRxiv in November. Prairie voles are socially monogamous, and after two of them bond, gene-expression patterns in their nucleus accumbens—a forebrain region linked to reward and social interaction—start to align. It remains unclear whether this transcriptional synchrony causes pair bonding or only correlates with it, she adds, but in the meantime, it offers researchers a new place to hunt for the basis of these strong social ties. This new study “pushes the limits of what’s possible” technically, says Robert Froemke, professor in New York University’s Neuroscience Institute and otolaryngology department, who was not involved in the study. Though the existence of neural synchrony logically suggests that there may also be shared patterns of gene expression, “it’s still remarkable to actually have it documented,” he says. The new preprint offers the first evidence of transcriptional synchrony in prairie voles, Donaldson says, but a 2020 study revealed that fighting pairs of Betta splendens fish show a strong correlation of gene expression after 60 minutes of fighting, and only a weak correlation after 20 minutes. © 2025 Simons Foundation

Keyword: Sexual Behavior
Link ID: 29630 - Posted: 01.15.2025

By Giorgia Guglielmi Amid the rising buzz around Ozempic and similar weight-loss drugs, a group of 58 researchers is challenging the way obesity is defined and diagnosed, arguing that current methods fail to capture the complexity of the condition. They offer a more nuanced approach. The group’s revised definition, published in The Lancet Diabetes & Endocrinology1 on 14 January, focuses on how excess body fat, a measure called adiposity, affects the body, rather than relying only on body mass index (BMI), which links a person’s weight to their height. They propose two categories: preclinical obesity, when a person has extra body fat but their organs work normally, and clinical obesity, when excess fat harms the body’s organs and tissues. This shift could improve clinical care, public-health policies and societal attitudes toward obesity, says Elisabeth van Rossum, an endocrinologist at the Erasmus University Medical Center Rotterdam in the Netherlands. “Now the idea is, eat less, move more, and you’ll lose weight,” says van Rossum, who wasn’t involved in the work. Although a healthy lifestyle is important, she adds, “if it would be so simple, we wouldn’t have an epidemic, and this paper is an excellent contribution to the discussion about the complexity of obesity”. Global problem More than 1 billion people worldwide live with obesity, and the condition is linked to about 5 million deaths every year2 from disorders such as diabetes and cardiovascular disease. Because it is easy to measure and compare, BMI has long been used as a tool to diagnose obesity. But it doesn’t offer a full picture of a person’s health, because it doesn’t account for differences in body composition, such as muscle versus fat. © 2025 Springer Nature Limited

Keyword: Obesity
Link ID: 29629 - Posted: 01.15.2025

By Jennifer Kahn Here’s a strange story: One day two summers ago, I woke up because my arms — both of them — hurt. Not the way they do when you’ve slept in a funny position, but as if the tendons in my forearms and hands were moving through mud. What felt like sharp electric shocks kept sparking in my fingers and sometimes up the inside of my biceps and across my chest. Holding anything was excruciating: a cup, a toothbrush, my phone. Even doing nothing was miserable. It hurt when I sat with my hands in my lap, when I stood, when I lay flat on the bed or on my side. The slightest pressure — a bedsheet, a watch band, a bra strap — was intolerable. It was August, and every doctor seemed to be away on vacation. The ones I did manage to see were politely stumped. It wasn’t carpal tunnel, tennis elbow or any other injury they could identify. I did nothing unusual the day before: an hour of work on my laptop, followed by a visit with a friend. We sat in her backyard and talked. For the first few weeks, I could barely sleep. Over the following months, I lost weight — almost a pound a week. I couldn’t drive, or cook, or use my laptop for work, or even hold a book or a pen. I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the house listening to audiobooks and doing voice-to-text searches for “nerve pain arms” with my phone flat on the table, then carefully, painfully, scrolling through the results. I think we’re past the point where I have to explain that chronic pain is not the result of imbalanced humors or a wandering uterus or possession by demons. But for more modern skeptics, this is where I should add that chronic pain also isn’t just “all in your head” or “not really that bad” — or any of the other ways in which people who suffer from it are still regularly gaslit and dismissed. Personally, I never had to contend with not being believed, almost certainly because I’m an otherwise healthy, reasonably well-off white woman with a clean medical history and no significant record of anxiety or depression. Instead, I was taken seriously. A whole gamut of tests was run. My wrists were X-rayed. I had an M.R.I. on my cervical spine. Each new doctor ordered new blood tests: some for vitamin deficiencies, others for autoimmune diseases like rheumatoid arthritis. © 2025 The New York Times Company

Keyword: Pain & Touch
Link ID: 29628 - Posted: 01.15.2025

By Meghan Rosen Baby Boomers may drive a bigger-than-expected boom in dementia cases. By 2060, 1 million U.S. adults per year will develop dementia, scientists predict January 13 in Nature Medicine. Dementia is a broad term encompassing many symptoms, including memory, reasoning and language difficulties that interfere with people’s daily lives. Researchers estimate that it currently affects more than 6 million people in the United States. “This is a huge problem,” says Josef Coresh, an epidemiologist at New York University’s Grossman School of Medicine. A rise in the projected number of dementia cases is not surprising, given the aging U.S. population ­­— but the extent of the rise stands out, he says. His team predicts that 42 percent of people in the United States who are over 55 years old will develop dementia sometime during their lifetime. That’s about double the percentage estimated by previous researchers. Coresh’s new estimate is based on a study population that’s larger — more than 15,000 people — and more diverse than earlier work. His team followed participants for years, in some cases decades, using several methods to identify dementia cases. They pored over hospital and death records, evaluated participants in person and screened them by phone. For the last decade, the researchers have been calling participants twice a year, Coresh says. That gave the team a window into people’s lives, revealing dementia cases that might otherwise have gone unreported. Though the team focused on dementia in people over age 55, risk doesn’t typically start ticking up for decades. And some populations were at greater risk than others, including women, Black people and those with a particular gene variant linked to Alzheimer’s disease. © Society for Science & the Public 2000–2025.

Keyword: Alzheimers
Link ID: 29627 - Posted: 01.15.2025